Birchview Capital, LP
BURLINGTON, VT · CIK 1618205 · 13F filing filed 2020-02-12
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityBIRCHVIEW CAPITAL, LP (US)
- Others nearbyBurlington, VT
$137.6m
reported value
52positions
79.1%in top 10
—no comparable previous quarter
Holdings, Q4 2019
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BRISTOL-MYERS SQUIBB CO BMY | $50.0m36.33% | — |
| ACCELERATE DIAGNOSTICS INC COM | $36.9m26.83% | — |
| NEUROCRINE BIOSCIENCES INC NBIX | $5.9m4.30% | — |
| QUIDEL CORP QDEL | $3.7m2.66% | — |
| OXFORD IMMUNOTEC GLOBAL PLC OXFD | $2.8m2.05% | — |
| VERMILLION INC COM NEW | $2.6m1.90% | — |
| BRISTOL-MYERS SQUIBB CO BMY-R | $2.1m1.53% | — |
| CONTRAFECT CORP CFRX | $1.8m1.28% | — |
| EQM MIDSTREAM PARTNERS LP EQM | $1.5m1.12% | — |
| KARYOPHARM THERAPEUTICS INC COM | $1.5m1.12% | — |
| SOLENO THERAPEUTICS INC COM | $1.5m1.09% | — |
| BIOGEN INC BIIB | $1.5m1.08% | — |
| HARROW INC HROW | $1.4m1.02% | — |
| VANDA PHARMACEUTICALS INC VNDA | $1.3m0.95% | — |
| AMARIN CORP PLC SPONS ADR NEW | $1.3m0.92% | — |
| MASIMO CORP MASI | $1.3m0.92% | — |
| ARVINAS INC ARVN | $1.2m0.90% | — |
| ALBIREO PHARMA INC BIOD | $1.2m0.89% | — |
| DERMIRA INC DERM | $1.2m0.88% | — |
| G1 THERAPEUTICS INC GTHX | $1.1m0.77% | — |
| INTERCEPT PHARMACEUTICALS IN ICPT | $1.0m0.75% | — |
| ARENA PHARMACEUTICALS INC ARNA | $999.0k0.73% | — |
| ACCELERON PHARMA INC XLRN | $990.0k0.72% | — |
| CHEMOCENTRYX INC CCXI | $989.0k0.72% | — |
| IMMUNOGEN INC IMGN | $919.0k0.67% | — |
| WRIGHT MEDICAL GROUP NV COM | $914.0k0.66% | — |
| MYRIAD GENETICS INC MYGN | $817.0k0.59% | — |
| QIAGEN NV SHS NEW | $676.0k0.49% | — |
| ODONATE THERAPEUTICS INC COM | $649.0k0.47% | — |
| CORCEPT THERAPEUTICS INC CORT | $605.0k0.44% | — |
| ACADIA PHARMACEUTICALS INC ACAD | $599.0k0.44% | — |
| PIONEER NAT RES CO PXD | $575.0k0.42% | — |
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $544.0k0.40% | — |
| KALVISTA PHARMACEUTICALS INC KALV | $534.0k0.39% | — |
| GOSSAMER BIO INC GOSS | $469.0k0.34% | — |
| UNITED THERAPEUTICS CORP DEL UTHR | $440.0k0.32% | — |
| XENCOR INC XNCR | $423.0k0.31% | — |
| VOYAGER THERAPEUTICS INC VYGR | $419.0k0.30% | — |
| PROGYNY INC PGNY | $412.0k0.30% | — |
| AMICUS THERAPEUTICS INC FOLD | $370.0k0.27% | — |
| SIENTRA INC SIEN | $358.0k0.26% | — |
| LEXICON PHARMACEUTICALS INC LXRX | $332.0k0.24% | — |
| VERACYTE INC VCYT | $301.0k0.22% | — |
| APELLIS PHARMACEUTICALS INC APLS | $245.0k0.18% | — |
| ENCANA CORP COM | $232.0k0.17% | — |
| DICERNA PHARMACEUTICALS INC DRNA | $220.0k0.16% | — |
| CONTINENTAL RES INC CLR | $206.0k0.15% | — |
| TG THERAPEUTICS INC TGTX | $167.0k0.12% | — |
| YIELD10 BIOSCIENCE INC COM | $130.0k0.09% | — |
| LIVENT CORP COM | $86.0k0.06% | — |
| WORKHORSE GROUP INC COM NEW | $76.0k0.06% | — |
| BIOCRYST PHARMACEUTICALS INC BCRX | $69.0k0.05% | — |